NO20010946L - Karbamat og ureasammensetninger og nevrotrofiske anvendelser - Google Patents
Karbamat og ureasammensetninger og nevrotrofiske anvendelserInfo
- Publication number
- NO20010946L NO20010946L NO20010946A NO20010946A NO20010946L NO 20010946 L NO20010946 L NO 20010946L NO 20010946 A NO20010946 A NO 20010946A NO 20010946 A NO20010946 A NO 20010946A NO 20010946 L NO20010946 L NO 20010946L
- Authority
- NO
- Norway
- Prior art keywords
- neurotrophic
- carbamate
- applications
- urea compositions
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/139,672 US6242468B1 (en) | 1997-02-27 | 1998-08-25 | Carbamate and urea compositions and neurotrophic uses |
PCT/US1999/019261 WO2000010553A2 (en) | 1998-08-25 | 1999-08-24 | Carbamate and urea compositions and neurotrophic uses |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20010946D0 NO20010946D0 (no) | 2001-02-23 |
NO20010946L true NO20010946L (no) | 2001-02-23 |
Family
ID=22487769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20010946A NO20010946L (no) | 1998-08-25 | 2001-02-23 | Karbamat og ureasammensetninger og nevrotrofiske anvendelser |
Country Status (18)
Country | Link |
---|---|
US (1) | US6242468B1 (hu) |
EP (1) | EP1107757A2 (hu) |
JP (1) | JP2002523367A (hu) |
KR (1) | KR20010072992A (hu) |
CN (1) | CN1313767A (hu) |
AU (1) | AU5687999A (hu) |
BG (1) | BG105340A (hu) |
BR (1) | BR9912988A (hu) |
CA (1) | CA2341530A1 (hu) |
CZ (1) | CZ2001274A3 (hu) |
EA (1) | EA200100271A1 (hu) |
HU (1) | HUP0103166A3 (hu) |
IL (1) | IL140958A0 (hu) |
MX (1) | MXPA01001937A (hu) |
NO (1) | NO20010946L (hu) |
PL (1) | PL346759A1 (hu) |
SK (1) | SK2562001A3 (hu) |
WO (1) | WO2000010553A2 (hu) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7008960B1 (en) | 1999-03-02 | 2006-03-07 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
EP1196386A2 (en) * | 1999-07-06 | 2002-04-17 | Vertex Pharmaceuticals Incorporated | N-substituted glycine derivatives |
US20030199574A1 (en) * | 2000-03-02 | 2003-10-23 | Vitreo-Retinal Technologies, Inc. | Treatment of ophthalmic disorders using urea and urea derivatives |
US7977385B2 (en) * | 2000-03-02 | 2011-07-12 | Numoda Biotechnologies, Inc. | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |
US20050137124A1 (en) * | 2002-08-09 | 2005-06-23 | Vitreo-Retinal Technologies, Inc. A California Corporation | Agents for intravitreal administration to treat or prevent disorders of the eye |
EP1402888A1 (en) * | 2002-09-18 | 2004-03-31 | Jerini AG | The use of substituted carbocyclic compounds as rotamases inhibitors |
US20050197356A1 (en) * | 2004-03-02 | 2005-09-08 | Wyeth | Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents |
EP1720886A1 (en) | 2004-03-02 | 2006-11-15 | Wyeth | Macrolides and methods for producing same |
WO2007061554A2 (en) * | 2005-10-21 | 2007-05-31 | Purdue Research Foundation | Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries |
CN104136413B (zh) * | 2011-12-27 | 2016-10-26 | 比皮艾思药物研发有限公司 | 用于预防或治疗癫痫症的苯基氨基甲酸酯化合物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI874163A (fi) | 1986-09-26 | 1988-03-27 | Mitsui Toatsu Chemicals | Katekolderivat samt preparat innehaollande desamma foer haemmande och botande av regressiva sjukdomar i det centrala nervsystemet. |
US5214034A (en) | 1986-09-26 | 1993-05-25 | Mitsui Toatsu Chemicals, Incorporated | Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same |
IT1206078B (it) | 1987-06-03 | 1989-04-14 | Polifarma Spa | Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico |
US5232923A (en) | 1988-03-18 | 1993-08-03 | Mitsui Toatsu Chemicals, Incorporated | Catechol derivatives and pharmaceutical preparations containing same |
US5166317A (en) | 1988-10-31 | 1992-11-24 | Houston Biotechnology Incorporated | Neurotrophic factor |
US5215969A (en) | 1989-08-11 | 1993-06-01 | Hahnemann University | Dopaminergic neurotrophic factor for treatment of Parkinson's disease |
US5620971A (en) | 1991-05-09 | 1997-04-15 | Vertex Pharmaceuticals Incorporated | Biologically active acylated amino acid derivatives |
US5744485A (en) | 1994-03-25 | 1998-04-28 | Vertex Pharmaceuticals Incorporated | Carbamates and ureas as modifiers of multi-drug resistance |
IL115685A (en) * | 1994-11-16 | 2000-08-31 | Vertex Pharma | Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof |
US6037370A (en) | 1995-06-08 | 2000-03-14 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5717092A (en) | 1996-03-29 | 1998-02-10 | Vertex Pharmaceuticals Inc. | Compounds with improved multi-drug resistance activity |
US5811434A (en) | 1996-11-13 | 1998-09-22 | Vertex Pharmacueticals Incorporated | Methods and compositions for stimulating neurite growth |
US5840736A (en) | 1996-11-13 | 1998-11-24 | Vertex Pharmaceuticals Incorporated | Methods and compositions for stimulating neurite growth |
US5780484A (en) | 1996-11-13 | 1998-07-14 | Vertex Pharmaceuticals Incorporated | Methods for stimulating neurite growth with piperidine compounds |
US5935989A (en) * | 1996-12-31 | 1999-08-10 | Gpi Nil Holdings Inc. | N-linked ureas and carbamates of heterocyclic thioesters |
ZA98825B (en) * | 1997-02-27 | 1998-10-19 | Guilford Pharm Inc | Method of using neurotrophic carbamates and ureas |
-
1998
- 1998-08-25 US US09/139,672 patent/US6242468B1/en not_active Expired - Fee Related
-
1999
- 1999-08-24 BR BR9912988-4A patent/BR9912988A/pt not_active IP Right Cessation
- 1999-08-24 CA CA002341530A patent/CA2341530A1/en not_active Abandoned
- 1999-08-24 KR KR1020017002444A patent/KR20010072992A/ko not_active Application Discontinuation
- 1999-08-24 MX MXPA01001937A patent/MXPA01001937A/es not_active IP Right Cessation
- 1999-08-24 EP EP99943869A patent/EP1107757A2/en not_active Withdrawn
- 1999-08-24 CN CN99810011A patent/CN1313767A/zh active Pending
- 1999-08-24 WO PCT/US1999/019261 patent/WO2000010553A2/en not_active Application Discontinuation
- 1999-08-24 PL PL99346759A patent/PL346759A1/xx unknown
- 1999-08-24 JP JP2000565875A patent/JP2002523367A/ja active Pending
- 1999-08-24 CZ CZ2001274A patent/CZ2001274A3/cs unknown
- 1999-08-24 AU AU56879/99A patent/AU5687999A/en not_active Abandoned
- 1999-08-24 SK SK256-2001A patent/SK2562001A3/sk unknown
- 1999-08-24 IL IL14095899A patent/IL140958A0/xx unknown
- 1999-08-24 HU HU0103166A patent/HUP0103166A3/hu unknown
- 1999-08-24 EA EA200100271A patent/EA200100271A1/ru unknown
-
2001
- 2001-02-23 NO NO20010946A patent/NO20010946L/no not_active Application Discontinuation
- 2001-03-14 BG BG105340A patent/BG105340A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1107757A2 (en) | 2001-06-20 |
HUP0103166A3 (en) | 2002-10-28 |
NO20010946D0 (no) | 2001-02-23 |
EA200100271A1 (ru) | 2001-10-22 |
CZ2001274A3 (cs) | 2001-09-12 |
JP2002523367A (ja) | 2002-07-30 |
IL140958A0 (en) | 2002-02-10 |
MXPA01001937A (es) | 2002-04-24 |
AU5687999A (en) | 2000-03-14 |
SK2562001A3 (en) | 2001-09-11 |
PL346759A1 (en) | 2002-02-25 |
WO2000010553A2 (en) | 2000-03-02 |
US6242468B1 (en) | 2001-06-05 |
CN1313767A (zh) | 2001-09-19 |
BG105340A (en) | 2001-12-29 |
BR9912988A (pt) | 2001-10-02 |
HUP0103166A2 (hu) | 2002-05-29 |
CA2341530A1 (en) | 2000-03-02 |
KR20010072992A (ko) | 2001-07-31 |
WO2000010553A3 (en) | 2000-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004110352A3 (en) | Compounds having activity in increasing ion transport by mutant-cftr and uses thereof | |
NO20010946L (no) | Karbamat og ureasammensetninger og nevrotrofiske anvendelser | |
BR0111878A (pt) | N-ureido-(heterociclo-alquil)-piperidinas como moduladores da atividade de receptores de quimiocinas | |
NO20060719L (no) | Substituerte cykloalkylaminderivater som modulatorer av kemokin reseptor aktivitet | |
NO20013003L (no) | Kinolin-derivater | |
NO20072352L (no) | Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet | |
ATE231145T1 (de) | Nichtpeptidische tachykinin-rezeptor-antagonisten | |
EA200601555A1 (ru) | Замещенные индазол-о-глюкозиды | |
NO20052493D0 (no) | Selekterte CGRP antagonister, fremgangsmater for fremstilling derav og deres anvendelse som farmasoytiske sammensetninger. | |
DK1362027T3 (da) | Acylerede 6,7,8,9-tetrahydro-5H-benzocycloheptenylaminer og deres anvendelse som farmaceutisk middel | |
WO2002059080A3 (en) | Trisubstituted carbocyclic cyclophilin binding compounds and their use | |
DK1091975T3 (da) | Ny cyclosporin med forbedret aktivitetsprofil | |
BRPI0620436A8 (pt) | compostos miméticos de lisina modificados, composição farmacêutica e uso | |
DK0754176T3 (da) | Hidtil ukendte carbamater og urinstoffer som modifikatorer for multidrugsresistens | |
NO20054787D0 (no) | Indenderivater som farmasotiske midler | |
NO20012977D0 (no) | N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet | |
NO20052524L (no) | Aminerte isofiavonoidderivater og anvendelse derav | |
WO2005090296A3 (en) | N-substituted benzene sulfonamides | |
ATE299494T1 (de) | Carbamat-derivate als muscarin-rezeptor antonisten | |
ATE380187T1 (de) | Agonisten und antagonisten für den lpa-rezeptor und anwendungsmethoden | |
WO2002072536A8 (en) | Urea derivatives having vanilloid receptor (vr1) antagonist activity | |
ATE302606T1 (de) | N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren | |
MY145074A (en) | Thiazolidin-4-one derivatives | |
DK1675591T3 (da) | Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer | |
HUP0002974A2 (hu) | Szulfonamidokkal N-szubsztituált heterociklusos tioészter-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |